Calton & Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $361K | Sell |
1,900
-3,329
| -64% | -$572K | 0.05% | 272 |
|
|
2026
Q1 | $883K | Sell |
5,229
-106
| -2% | -$18.1K | 0.13% | 152 |
|
|
2025
Q4 | $900K | Sell |
5,335
-169
| -3% | -$27.4K | 0.13% | 148 |
|
|
2025
Q3 | $795K | Buy |
5,504
+81
| +1% | +$11.1K | 0.12% | 163 |
|
|
2025
Q2 | $686K | Sell |
5,423
-82
| -1% | -$10.1K | 0.12% | 163 |
|
|
2025
Q1 | $704K | Sell |
5,505
-111
| -2% | -$15.1K | 0.16% | 124 |
|
|
2024
Q4 | $743K | Buy |
5,616
+3,034
| +118% | +$427K | 0.33% | 76 |
|
|
2024
Q3 | $376K | Sell |
2,582
-3,255
| -56% | -$471K | 0.14% | 145 |
|
|
2024
Q2 | $801K | Sell |
5,837
-429
| -7% | -$57.3K | 0.4% | 65 |
|
|
2024
Q1 | $860K | Sell |
6,266
-398
| -6% | -$54.4K | 0.42% | 57 |
|
|
2023
Q4 | $905K | Buy |
+6,664
| New | +$813K | 0.36% | 64 |
|
|
2023
Q3 | – | Sell |
-7,045
| Closed | -$894K | – | 179 |
|
|
2023
Q2 | $894K | Sell |
7,045
-83
| -1% | -$10.8K | 0.42% | 66 |
|
|
2023
Q1 | $921K | Sell |
7,128
-316
| -4% | -$41.4K | 0.43% | 64 |
|
|
2022
Q4 | $977K | Buy |
7,444
+3,694
| +99% | +$477K | 0.38% | 65 |
|
|
2022
Q3 | $438K | Buy |
3,750
+2
| +0.1% | +$248 | 0.25% | 99 |
|
|
2022
Q2 | $440K | Sell |
3,748
-357
| -9% | -$42.4K | 0.24% | 106 |
|
|
2022
Q1 | $534K | Sell |
4,105
-585
| -12% | -$76.2K | 0.16% | 154 |
|
|
2021
Q4 | $715K | Sell |
4,690
-723
| -13% | -$112K | 0.19% | 135 |
|
|
2021
Q3 | $875K | Buy |
5,413
+1,219
| +29% | +$205K | 0.19% | 131 |
|
|
2021
Q2 | $687K | Buy |
4,194
+287
| +7% | +$44.2K | 0.13% | 163 |
|
|
2021
Q1 | $588K | Sell |
3,907
-72
| -2% | -$11.4K | 0.11% | 169 |
|
|
2020
Q4 | $603K | Sell |
3,979
-839
| -17% | -$120K | 0.11% | 156 |
|
|
2020
Q3 | $652K | Sell |
4,818
-680
| -12% | -$92.3K | 0.13% | 129 |
|
|
2020
Q2 | $752K | Sell |
5,498
-4,722
| -46% | -$602K | 0.16% | 105 |
|
|
2020
Q1 | $1.1M | Sell |
10,220
-737
| -7% | -$84.9K | 0.27% | 69 |
|
|
2019
Q4 | $1.32M | Sell |
10,957
-394
| -3% | -$44K | 0.27% | 72 |
|
|
2019
Q3 | $1.13M | Buy |
11,351
+342
| +3% | +$35.8K | 0.25% | 74 |
|
|
2019
Q2 | $1.2M | Sell |
11,009
-290
| -3% | -$30.8K | 0.34% | 53 |
|
|
2019
Q1 | $1.26M | Sell |
11,299
-805
| -7% | -$88.3K | 0.38% | 50 |
|
|
2018
Q4 | $1.17M | Buy |
12,104
+133
| +1% | +$14.1K | 0.43% | 49 |
|
|
2018
Q3 | $1.46M | Sell |
11,971
-28
| -0.2% | -$3.3K | 0.43% | 38 |
|
|
2018
Q2 | $1.41M | Buy |
11,999
+1,796
| +18% | +$192K | 0.41% | 41 |
|
|
2018
Q1 | $1.09M | Buy |
10,203
+59
| +0.6% | +$6.54K | 0.32% | 66 |
|
|
2017
Q4 | $1.18M | Buy |
+10,144
| New | +$1.08M | 0.3% | 57 |
|
Other funds holding IBB
CB
Calton & Associates's IBB Position: Q2 2026 in Review
Calton & Associates reduced its iShares Biotechnology ETF (IBB) stake by 64% in Q2 2026, selling an estimated $572K and leaving 1,900 shares worth $361K. The position accounts for 0.05% of the portfolio, ranked #272.
Calton & Associates first reported a position in IBB in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.46M in Q3 2018. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Calton & Associates held 1,900 shares of iShares Biotechnology ETF worth $361K as of Q2 2026.
- Calton & Associates sold 3,329 iShares Biotechnology ETF shares in Q2 2026, an estimated $572K.
- iShares Biotechnology ETF made up 0.05% of Calton & Associates's portfolio in Q2 2026, its #272 holding.
- Calton & Associates first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 34 quarters since.
- Calton & Associates's iShares Biotechnology ETF position peaked at $1.46M in Q3 2018.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.